Company Data
Tiziana Life Sciences Ltd
Ticker
TLSA
Current Price
$1.41 -3.42%
Market Cap
$179.4M
Price Target
Refer to Report
Volume
228.1K
52wk Range
$1.14 - $2.6
Overview
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for autoimmune and inflammatory diseases, degenerative diseases, and cancer-related to the liver. Its clinical pipeline includes drug assets for Crohn’s Disease, COVID19, Secondary Progressive Multiple Sclerosis, and Hepatocellular Carcinoma. Its development pipeline includes Foralumab, Milciclib, Anti-IL6R, and Others. The company has a single reporting segment, which is the research and development of biotechnological & pharmaceutical products.